Section 663.10  Definitions

For the purpose of this Part, the following shall be the accepted definitions of the terms used in this Part:

"Act" means the Sickle Cell Prevention, Care, and Treatment Program Act [410 ILCS 460].

"Department" or "DPH" means the Illinois Department of Public Health or its designee.

"Director" means Director of the Illinois Department of Public Health.

"Hemoglobinopathies" means rare inborn disorders that impair the red blood cells’ ability to carry oxygen to the body’s organs and tissues.

"Fund" means the Sickle Cell Chronic Disease Fund as established by the Act.

"Funding period" means the time (usually 12 months coinciding with the Department's fiscal year) during which money is to be spent by award recipients.

"Program" means the Sickle Cell Prevention, Care, and Treatment Program. (Section 131-5 of the Act)

"Sickle cell disease" (SCD) and "sickling disorder" means a rare inborn disorder that impairs the red blood cells' ability to carry oxygen to the body's organs and tissues. A change in the shape of the red blood cells may occur, at times resembling a sickle shape.

"Sickle cell trait" (SCT) and "sickle trait" means the heritable change in the hemoglobin gene that is associated with sickle cell disease.